ClearBridge Investments
MIRM icon

ClearBridge Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

ClearBridge Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.9M Sell
639,734
-32,136
-5% -$3.23M 0.06% 265
2026
Q1 		$62.1M Sell
671,870
-194,097
-22% -$18.3M 0.05% 280
2025
Q4 		$68.4M Sell
865,967
-137,836
-14% -$9.89M 0.05% 287
2025
Q3 		$73.6M Sell
1,003,803
-23,724
-2% -$1.51M 0.06% 281
2025
Q2 		$52.3M Buy
1,027,527
+49,460
+5% +$2.2M 0.04% 308
2025
Q1 		$44.1M Buy
978,067
+70,750
+8% +$3.33M 0.04% 326
2024
Q4 		$37.5M Buy
907,317
+18,217
+2% +$759K 0.03% 353
2024
Q3 		$34.7M Buy
889,100
+189,167
+27% +$7.55M 0.03% 378
2024
Q2 		$23.9M Buy
699,933
+436,349
+166% +$11.4M 0.02% 426
2024
Q1 		$6.62M Sell
263,584
-513
-0.2% -$14.1K 0.01% 574
2023
Q4 		$7.8M Buy
264,097
+247,933
+1,534% +$7.5M 0.01% 558
2023
Q3 		$511K Sell
16,164
-4,400
-21% -$120K ﹤0.01% 650
2023
Q2 		$532K Sell
20,564
-30,381
-60% -$808K ﹤0.01% 663
2023
Q1 		$1.22M Buy
50,945
+19,790
+64% +$451K ﹤0.01% 636
2022
Q4 		$608K Buy
31,155
+10,470
+51% +$207K ﹤0.01% 693
2022
Q3 		$435K Sell
20,685
-12
-0.1% -$289 ﹤0.01% 699
2022
Q2 		$403K Hold
20,697
– – ﹤0.01% 725
2022
Q1 		$456K Buy
+20,697
New +$422K ﹤0.01% 736

Other funds holding MIRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

ClearBridge Investments's MIRM Position: Q2 2026 in Review

ClearBridge Investments reduced its Mirum Pharmaceuticals (MIRM) stake by 4.8% in Q2 2026, selling an estimated $3.23M and leaving 639,734 shares worth $74.9M. The position accounts for 0.06% of the portfolio, ranked #265.

ClearBridge Investments first reported a position in MIRM in Q1 2022 and has held it in 18 quarters since. 226 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • ClearBridge Investments held 639,734 shares of Mirum Pharmaceuticals worth $74.9M as of Q2 2026.
  • ClearBridge Investments sold 32,136 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.23M.
  • Mirum Pharmaceuticals made up 0.06% of ClearBridge Investments's portfolio in Q2 2026, its #265 holding.
  • ClearBridge Investments first reported a position in Mirum Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • 226 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.